Kyrylo Perevozchykov

Kyrylo Perevozchykov serves as Chief Technology Officer at Esper Bionics. Esper Bionics operates in the medical devices sector with approximately 48.0 employees. To date, Esper Bionics has raised 150000.0 in total funding, with the most recent round being Other.

Industry & Role Insights

• • MessageCEO tracks 1,888 executives in the medical devices sector.
• • We have verified contacts for 2 executives at Esper Bionics.
• • Our database includes 201,468 c suite-level executives.

Gmail Google Apps Amazon AWS Mobile Friendly Typekit Google Font API Vimeo Google Tag Manager Remote AI

robotics prosthetics ai data science hardware iot myoelectric healthtech medtech dsp mechatronics wearables human augmentatio orthotics controllers medical equipment manufacturing human augmentation bionic prosthetics ai-driven technology self-learning prosthetics intuitive control advanced prosthetic devices esper hand emg control anatomical design lightweight construction passive flexion user-centric ecosystem wearable devices assistive technology limb differences independence mobility quality of life amputees rehabilitation prosthetic innovation robotic limbs sensor technology healthcare solutions mass market applications user experience social integration advanced wearables prosthetics industry human enhancement technology for disabilities economic opportunities military service user adaptation aesthetic appeal diverse demographics competitive landscape mechanical or industrial engineering information technology & services consumer goods consumers medical devices hospital & health care ux

AB

Anna Believantseva Chief Operational Officer at Esper Bionics

YM

Yahia Megahed CEO at 360Imaging

HA

Hugo Azevedo Chief Technology Officer at 3B Scientific

MP

Marie-Laure Pochon CEO & President at 3DISC

KD

Khanh Duy Co-CEO at 3D-Side

Outreach Guidance — medical devices Sector

Executives like Kyrylo Perevozchykov in the medical devices sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at Esper Bionics.

Kyrylo Perevozchykov's Position in the MessageCEO Database

• •Kyrylo Perevozchykov is 1 of 2 verified executive contacts we track at Esper Bionics.
• •1,787 verified executive contacts in medical devices are in the MessageCEO database.
• •18 verified contacts work at medical devices companies in the 48.0 employee range (same size as Esper Bionics).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated July 2026.

How do I reach Kyrylo Perevozchykov directly?

Kyrylo Perevozchykov's verified email address is available to MessageCEO Pro subscribers. They currently serve as Chief Technology Officer at Esper Bionics. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Kyrylo Perevozchykov work for?

Kyrylo Perevozchykov is Chief Technology Officer at Esper Bionics, a company in the medical devices sector with 48.0 employees.

Can I pitch or sell to Kyrylo Perevozchykov?

As Chief Technology Officer at Esper Bionics, Kyrylo Perevozchykov is a key decision-maker in the medical devices sector. MessageCEO Pro gives you verified email to reach Kyrylo Perevozchykov directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Kyrylo Perevozchykov in?

Kyrylo Perevozchykov works in the medical devices industry as Chief Technology Officer at Esper Bionics. MessageCEO provides verified contact information for executives across all major industries.

Is Kyrylo Perevozchykov's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Kyrylo Perevozchykov's profile is kept up-to-date with the latest available information.

Last updated: July 29, 2026